help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CHRISTENSON, J.
Right arrow Articles by HALL, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CHRISTENSON, J.
Right arrow Articles by HALL, J. B.

Am. J. Respir. Crit. Care Med., Volume 161, Number 5, May 2000, 1443-1449

The Incidence and Pathogenesis of Cardiopulmonary Deterioration after Abrupt Withdrawal of Inhaled Nitric Oxide

JEFFERY CHRISTENSON, ANNICK LAVOIE, MICHAEL O'CONNOR, SANGEETA BHORADE, ANNE POHLMAN, and JESSE B. HALL

Departments of Medicine and Anesthesia and Critical Care, The Pritzker School of Medicine, University of Chicago, Chicago, Illinois

We studied the effect of abrupt discontinuation of inhaled nitric oxide (iNO) in patients receiving this drug for treatment of acute hypoxemic respiratory failure (AHRF), in order to determine the need for continued therapy, the incidence and nature of adverse events, and the risk factors predicting these adverse events. Thirty-one patients who showed an initial increase in PaO2 of > 20 mm Hg in response to iNO underwent a discontinuation trial at 10 to 30 h after beginning iNO. Indwelling arterial and pulmonary artery catheters facilitated monitoring of hemodynamic and gas-exchange parameters. For the group, discontinuation of iNO caused a significant decrease in PaO2 , arterial and mixed venous oxygen saturation, and ratio of PaO2 to fraction of inspired oxygen (FIO2). Three patterns of response were observed. Eight of 31 (25.8%) patients had minimal changes in oxygenation or hemodynamics, suggesting no need for ongoing therapy. Fifteen of 31 (48%) patients had worsened gas exchange as a predominant response. Eight of 31 patients exhibited hemodynamic collapse, defined as > 20% fall in cardiac output and/or mean arterial blood pressure. In this last subgroup, the pattern of cardiovascular changes suggested that this response arose from an acute increase in right ventricular afterload, and was not a consequence of gas-exchange abnormalities. In all cases, reinstitution of iNO promptly reversed worsened hemodynamics and gas exchange. Independent factors associated with an increased risk of cardiovascular collapse included multisystem organ failure, older age, and initial blood pressure increase in response to iNO; a smaller change in the ratio of PaO2 to FIO2 with initiation of iNO therapy also tended to correlate with this phenomenon. We conclude that careful and monitored discontinuation of iNO in patients with AHRF will identify substantial fractions of patients who are either receiving no benefit from this therapy or who require iNO to maintain an adequate circulation and are therefore at risk for adverse outcome with transport or inadvertent discontinuation of iNO. Future trials of iNO should recognize this complication of such therapy and include assessments for it.




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Natori, N. Hasebe, Y.-T. Jin, T. Matsusaka, A. Ido, H. Matsuhashi, T. Ihara, and K. Kikuchi
Inhaled Nitric Oxide Modifies Left Ventricular Diastolic Stress in the Presence of Vasoactive Agents in Heart Failure
Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 895 - 901.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. F. Lam, P. V. van Heerden, K. F. Ilett, P. Caterina, and P. Filion
Two Aerosolized Nitric Oxide Adducts as Selective Pulmonary Vasodilators for Acute Pulmonary Hypertension
Chest, March 1, 2003; 123(3): 869 - 874.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Y. Kirov, O. V. Evgenov, V. N. Kuklin, L. Virag, P. Pacher, G. J. Southan, A. L. Salzman, C. Szabo, and L. J. Bjertnaes
Aerosolized Linear Polyethylenimine-Nitric Oxide/Nucleophile Adduct Attenuates Endotoxin-induced Lung Injury in Sheep
Am. J. Respir. Crit. Care Med., December 1, 2002; 166(11): 1436 - 1442.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Critical Care Medicine in AJRCCM 2000
Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1347 - 1361.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. P. Moya, A. J. Gow, T. J. McMahon, E. J. Toone, I. M. Cheifetz, R. N. Goldberg, and J. S. Stamler
S-nitrosothiol repletion by an inhaled gas regulates pulmonary function
PNAS, April 18, 2001; (2001) 91109498.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. P. Moya, A. J. Gow, T. J. McMahon, E. J. Toone, I. M. Cheifetz, R. N. Goldberg, and J. S. Stamler
S-nitrosothiol repletion by an inhaled gas regulates pulmonary function
PNAS, May 8, 2001; 98(10): 5792 - 5797.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2000 American Thoracic Society 		  CCM abstracts